Several leading firms worldwide focus on the production of complex medicinal APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone Mesylate. These molecules present significant difficulties in synthetic development due to their structural complexity. The producers of these APIs often employ specialized technologies and adhere to strict r